Osorio, Catarina , CHACON FERNANDEZ, PEDRO JOSE, White, Matthew , Kisiswa, Lilian , Wyatt, Sean , Rodriguez-Tebar, Alfredo , Davies, Alun M.
No
Mol. Cell. Neurosci.
Article
Científica
3.84
2.395
01/03/2014
000336338400003
APRIL (A Proliferation-Inducing Ligand, TNFSF13) is a member of the tumor necrosis factor superfamily that regulates lymphocyte survival and activation and has been implicated in tumorigenesis and autoimmune diseases. Here we report the expression and first known activity of APRIL in the nervous system. APRIL and one of its receptors, BCMA (B-Cell Maturation Antigen, TNFRSF17), are expressed by hippocampal pyramidal cells of fetal and postnatal mice. In culture, these neurons secreted APRIL, and function-blocking antibodies to either APRIL or BCMA reduced axonal elongation. Recombinant APRIL enhanced axonal elongation, but did not influence dendrite elongation. The effect of APRIL on axon elongation was inhibited by anti-BCMA and the expression of a signaling-defective BCMA mutant in these neurons, suggesting that the axon growth-promoting effect of APRIL is mediated by BCMA. APRIL promoted phosphorylation and activation of ERK1, ERK2 and Akt and serine phosphorylation and inactivation of GSK-3 beta in cultured hippocampal pyramidal cells. Inhibition of MEK1/MEK2 (activators of ERK1/ERK2), PI3-kinase (activator of Akt) or Akt inhibited the axon growth-promoting action of APRIL, as did pharmacological activation of GSK-3 beta and the expression of a constitutively active form of GSK-3 beta. These findings suggest that APRIL promotes axon elongation by a mechanism that depends both on ERK signaling and PI3-kinase/Akt/GSK-3 beta signaling. (C) 2014 The Authors. Published by Elsevier Inc. All rights reserved.
Hippocampal pyramidal cell; Axon; Tumor necrosis factor superfamily; Tumor necrosis factor receptor superfamily